Clinical Trial Update: Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing topical terbinafine hydrochloride 10% with amorolfine 5% nail lacquer for mild to moderate toenail onychomycosis assessed efficacy, safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• Amorolfine nail lacquer 5% (amorolfine)
• Terbinafine hydrochloride topical 10% (terbinafine hydrochloride)

Snippet

Sponsor: Novartis | Conditions: Onychomycosis | Phase 3 | Status: COMPLETED | Results posted: 2011-04-20